Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Beginning Balance (in shares) at Dec. 31, 2021   0 39,692,373      
Beginning Balance at Dec. 31, 2021 $ 696,304 $ 0 $ 4 $ 121,844 $ 573,546 $ 910
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net and comprehensive (loss) income 30,283       32,783 (2,500)
Dividend (52,136)       (52,136)  
Stock-based compensation 3,856     3,856    
Issuance of common stock for vesting of restricted stock units (in shares)     167,263      
Shares withheld related to net share settlement of stock-based awards (in shares)     (64,237)      
Shares withheld related to net share settlement of stock-based awards (2,918)     (2,918)    
Ending Balance (in shares) at Mar. 31, 2022   0 39,795,399      
Ending Balance at Mar. 31, 2022 675,389 $ 0 $ 4 122,782 554,193 (1,590)
Beginning Balance (in shares) at Dec. 31, 2022   0 39,255,838      
Beginning Balance at Dec. 31, 2022 713,509 $ 0 $ 4 131,541 585,581 (3,617)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net and comprehensive (loss) income (4,663)       (5,833) 1,170
Dividend (10,284)       (10,284)  
Stock-based compensation 5,011     5,011    
Issuance of common stock for vesting of restricted stock units (in shares)     293,873      
Shares withheld related to net share settlement of stock-based awards (in shares)     (113,434)      
Shares withheld related to net share settlement of stock-based awards (3,647)     (3,647)    
Repurchases of common stock (in shares)     (559,923)      
Repurchases of common stock (17,768)       (17,768)  
Ending Balance (in shares) at Mar. 31, 2023   0 38,876,354      
Ending Balance at Mar. 31, 2023 $ 682,158 $ 0 $ 4 $ 132,905 $ 551,696 $ (2,447)